VeriChip Corporation to Launch Direct-to-Consumer Campaign
22 4์ 2008 - 9:30PM
Business Wire
VeriChip Corporation (the ๏ฟฝCompany๏ฟฝ) (NASDAQ:CHIP), a provider of
radio frequency identification (RFID) systems for healthcare and
patient-related needs, will launch its first-ever
direct-to-consumer (DTC) marketing campaign in South Florida on
April 28. As part of this campaign, the Company has renamed its
patient identification system Health Link and created a new website
at www.healthlinkinfo.com that will go live at the campaign launch.
The site will provide complete information about the product and
how to enroll as a Health Link member. VeriChip has also entered
into a relationship with HearUSA, Inc. (AMEX:EAR), a leading
provider of hearing care, which has eight HEARx locations
throughout the Palm Beach market where patients can enroll in
Health Link. Health Link is the connection between you and your
personal health record. It provides emergency room doctors and
nurses with immediate access to your vital medical and emergency
contact information, which will help them to treat you rapidly,
accurately and safely during an emergency. Health Link utilizes a
tiny microchip (similar in size to a grain of rice) and a secure,
private, online database that links you to your personal health
record. Your Health Link is always with you and cannot be lost or
stolen. The Health Link microchip stores only a unique 16-digit
identification number and is injected just under the skin in the
rear upper portion of the right arm. When a Health Link member
presents in an emergency department unconscious, unresponsive or
confused, emergency medical personnel use the Health Link scanner
to retrieve the member๏ฟฝs identification number to access his or her
personal health record. Scott R. Silverman, Chairman and CEO of
VeriChip, said, ๏ฟฝGiven our successful infrastructure build-out in
South Florida, we are now ready to escalate our marketing efforts
to increase consumer awareness and adoption through the first DTC
launch of our product. We chose to partner with HearUSA because of
their impeccable reputation as a quality provider of hearing health
care. This partnership also allows us to offer consumers a
convenient location in a professional setting where they can be
educated on Health Link and enroll as a member.๏ฟฝ To lead its DTC
launch, VeriChip has hired Samuel Ambrose as vice president of
business development. Ambrose brings more than 16 years of sales
and marketing experience to VeriChip, including senior sales and
marketing positions with Office Depot, Boston Market and the
Florida Panthers. He has a proven track record of bringing products
to market successfully and his experience includes development of
local, regional and national level marketing and advertising plans
designed to build incremental sales. Silverman said, ๏ฟฝWe are
fortunate to have a well-respected and highly capable marketing
executive like Samuel Ambrose to lead this important effort of
growing our Health Link business and producing consistent revenue
from subscribers.๏ฟฝ About HearUSA HearUSA, Inc. provides hearing
care to patients primarily through more than 190 company-owned
hearing care centers, which offer a complete range of quality
hearing aids with an emphasis on the latest digital technology.
HearUSA Centers are located in California, Florida, New York, New
Jersey, Massachusetts, Ohio, Michigan, Missouri, North Carolina,
and the province of Ontario, Canada. The company also derives
revenues from its HearUSA Hearing Care Network, comprised of 1,900
affiliated audiologists in 49 states, as well as its website that
enables online purchases of hearing related products, such as
batteries, hearing aid accessories and assistive listening devices.
For further information, click on "investor information" at the
HearUSA website: www.hearusa.com. About VeriChip VeriChip
Corporation, headquartered in Delray Beach, Florida, develops,
markets and sells RFID systems used to identify, locate and protect
people and assets. VeriChip's goal is to become the leading
provider of RFID systems for people in the healthcare industry. The
Company recently began marketing Health Link, a passive RFID system
for rapidly and accurately identifying people who arrive in an
emergency room and are unable to communicate. This system uses the
first human-implantable passive RFID microchip cleared for medical
use in October 2004 by the United States Food and Drug
Administration. For more information on VeriChip, please call
1-800-970-2447, or email info@verichipcorp.com. Additional
information can be found online at http://www.verichipcorp.com.
Statements about the Company's future expectations, including
growth of the business, future revenues and earnings, and all other
statements in this press release other than historical facts are
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as that term is defined in the Private Litigation
Reform Act of 1995. Such forward-looking statements involve risks
and uncertainties and are subject to change at any time, and the
Company's actual results could differ materially from expected
results. Information about factors that could affect the Company๏ฟฝs
business is set forth in the Company๏ฟฝs various filings with the
Securities and Exchange Commission, including those set forth in
the Company๏ฟฝs 10-K filed on March 28, 2008, under the caption ๏ฟฝRisk
Factors.๏ฟฝ The Company undertakes no obligation to update or release
any revisions to these forward-looking statements to reflect events
or circumstances after the date of this statement or to reflect the
occurrence of unanticipated events, except as required by law.
Verichip (MM) (NASDAQ:CHIP)
๊ณผ๊ฑฐ ๋ฐ์ดํฐ ์ฃผ์ ์ฐจํธ
๋ถํฐ 6์(6) 2024 ์ผ๋ก 7์(7) 2024
Verichip (MM) (NASDAQ:CHIP)
๊ณผ๊ฑฐ ๋ฐ์ดํฐ ์ฃผ์ ์ฐจํธ
๋ถํฐ 7์(7) 2023 ์ผ๋ก 7์(7) 2024